fanta.bio Sample: CNhs11352
13995 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1002 / 10134 (9.9%) | 303 / 101340 (0.3%) | −324.0 | −324.0 | 33.07 |
| HIF1A SRX11007095 | HK-2 Kidney | 1758 / 10134 (17.3%) | 634 / 101340 (0.6%) | −324.0 | −324.0 | 27.73 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1424 / 10134 (14.1%) | 529 / 101340 (0.5%) | −324.0 | −324.0 | 26.92 |
| TP53 SRX19538279 | Osteoblasts Bone | 457 / 10134 (4.5%) | 177 / 101340 (0.2%) | −324.0 | −324.0 | 25.82 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1221 / 10134 (12.0%) | 564 / 101340 (0.6%) | −324.0 | −324.0 | 21.65 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1694 / 10134 (16.7%) | 850 / 101340 (0.8%) | −324.0 | −324.0 | 19.93 |
| SCML2 SRX644728 | 293 Kidney | 1042 / 10134 (10.3%) | 540 / 101340 (0.5%) | −324.0 | −324.0 | 19.30 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1624 / 10134 (16.0%) | 851 / 101340 (0.8%) | −324.0 | −324.0 | 19.08 |
| MYH11 SRX265221 | ME-1 Blood | 628 / 10134 (6.2%) | 394 / 101340 (0.4%) | −324.0 | −324.0 | 15.94 |
| FOXP1 SRX736067 | LNCAP Prostate | 1281 / 10134 (12.6%) | 827 / 101340 (0.8%) | −324.0 | −324.0 | 15.49 |
| MED1 SRX9419944 | BT-474 Breast | 2358 / 10134 (23.3%) | 1898 / 101340 (1.9%) | −324.0 | −324.0 | 12.42 |
| BRD4 SRX9419935 | BT-474 Breast | 2395 / 10134 (23.6%) | 1928 / 101340 (1.9%) | −324.0 | −324.0 | 12.42 |
| MED1 SRX9419945 | BT-474 Breast | 2377 / 10134 (23.5%) | 1939 / 101340 (1.9%) | −324.0 | −324.0 | 12.26 |
| BRD4 SRX9419937 | BT-474 Breast | 2411 / 10134 (23.8%) | 1967 / 101340 (1.9%) | −324.0 | −324.0 | 12.26 |
| MED1 SRX9419946 | BT-474 Breast | 2430 / 10134 (24.0%) | 2013 / 101340 (2.0%) | −324.0 | −324.0 | 12.07 |
| BRD4 SRX9419938 | BT-474 Breast | 2383 / 10134 (23.5%) | 2024 / 101340 (2.0%) | −324.0 | −324.0 | 11.77 |
| BRD4 SRX9419936 | BT-474 Breast | 2415 / 10134 (23.8%) | 2057 / 101340 (2.0%) | −324.0 | −324.0 | 11.74 |
| MED1 SRX9419947 | BT-474 Breast | 2341 / 10134 (23.1%) | 1999 / 101340 (2.0%) | −324.0 | −324.0 | 11.71 |
| BRD4 SRX736201 | 90-8TL Neural | 4159 / 10134 (41.0%) | 4389 / 101340 (4.3%) | −324.0 | −324.0 | 9.48 |
| EZH2 SRX2146136 | LNCAP Prostate | 4936 / 10134 (48.7%) | 5524 / 101340 (5.5%) | −324.0 | −324.0 | 8.94 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1223 / 10134 (12.1%) | 1739 / 101340 (1.7%) | −324.0 | −324.0 | 7.03 |
| TP53 SRX19538268 | U2OS Bone | 367 / 10134 (3.6%) | 110 / 101340 (0.1%) | −278.7 | −275.5 | 33.36 |
| TP53 SRX19538276 | U2OS Bone | 374 / 10134 (3.7%) | 126 / 101340 (0.1%) | −276.1 | −272.9 | 29.68 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1017 / 10134 (10.0%) | 2345 / 101340 (2.3%) | −275.4 | −272.3 | 4.34 |
| TP53 SRX19538274 | U2OS Bone | 361 / 10134 (3.6%) | 120 / 101340 (0.1%) | −267.3 | −264.2 | 30.08 |
| RUNX1 SRX2513054 | 293 Kidney | 2348 / 10134 (23.2%) | 10667 / 101340 (10.5%) | −258.1 | −255.0 | 2.20 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1153 / 10134 (11.4%) | 3187 / 101340 (3.1%) | −257.7 | −254.6 | 3.62 |
| TP53 SRX19538280 | Osteoblasts Bone | 363 / 10134 (3.6%) | 148 / 101340 (0.1%) | −254.4 | −251.3 | 24.53 |
| BRD4 SRX736204 | 90-8TL Neural | 829 / 10134 (8.2%) | 1697 / 101340 (1.7%) | −249.8 | −246.7 | 4.89 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 537 / 10134 (5.3%) | 602 / 101340 (0.6%) | −248.2 | −245.1 | 8.92 |
| TP53 SRX19538267 | U2OS Bone | 332 / 10134 (3.3%) | 108 / 101340 (0.1%) | −247.1 | −244.1 | 30.74 |
| TP53 SRX19538275 | U2OS Bone | 336 / 10134 (3.3%) | 118 / 101340 (0.1%) | −245.2 | −242.2 | 28.47 |
| AGO2 SRX4708039 | Hep G2 Liver | 1387 / 10134 (13.7%) | 4659 / 101340 (4.6%) | −242.8 | −239.8 | 2.98 |
| TP53 SRX19538281 | Osteoblasts Bone | 378 / 10134 (3.7%) | 204 / 101340 (0.2%) | −242.3 | −239.3 | 18.53 |
| TP53 SRX19538273 | U2OS Bone | 324 / 10134 (3.2%) | 106 / 101340 (0.1%) | −240.8 | −237.8 | 30.57 |
| HIF1A SRX20663235 | HK-2 Kidney | 355 / 10134 (3.5%) | 180 / 101340 (0.2%) | −232.4 | −229.4 | 19.72 |
| TP53 SRX19538269 | U2OS Bone | 399 / 10134 (3.9%) | 286 / 101340 (0.3%) | −229.4 | −226.5 | 13.95 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 511 / 10134 (5.0%) | 617 / 101340 (0.6%) | −225.9 | −222.9 | 8.28 |
| 5-mC SRX882970 | LNCAP Prostate | 2050 / 10134 (20.2%) | 9232 / 101340 (9.1%) | −224.8 | −221.9 | 2.22 |
| IRF3 SRX11453858 | Hep G2 Liver | 275 / 10134 (2.7%) | 63 / 101340 (0.1%) | −221.1 | −218.1 | 43.65 |
| 5-mC SRX882968 | LNCAP Prostate | 2021 / 10134 (19.9%) | 9183 / 101340 (9.1%) | −217.1 | −214.2 | 2.20 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1521 / 10134 (15.0%) | 5862 / 101340 (5.8%) | −216.2 | −213.3 | 2.59 |
| TP53 SRX19538270 | U2OS Bone | 372 / 10134 (3.7%) | 276 / 101340 (0.3%) | −210.7 | −207.8 | 13.48 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 318 / 10134 (3.1%) | 163 / 101340 (0.2%) | −207.3 | −204.5 | 19.51 |
| CIC SRX13262055 | Astrocytes Neural | 2118 / 10134 (20.9%) | 10096 / 101340 (10.0%) | −206.3 | −203.4 | 2.10 |
| TP53 SRX19538271 | U2OS Bone | 515 / 10134 (5.1%) | 737 / 101340 (0.7%) | −204.0 | −201.1 | 6.99 |
| TP53 SRX19538282 | Osteoblasts Bone | 322 / 10134 (3.2%) | 209 / 101340 (0.2%) | −192.6 | −189.8 | 15.41 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 462 / 10134 (4.6%) | 626 / 101340 (0.6%) | −189.6 | −186.8 | 7.38 |
| 5-mC SRX882965 | LNCAP Prostate | 1650 / 10134 (16.3%) | 7179 / 101340 (7.1%) | −189.0 | −186.2 | 2.30 |
| IRF3 SRX11453861 | Hep G2 Liver | 239 / 10134 (2.4%) | 63 / 101340 (0.1%) | −186.6 | −183.8 | 37.94 |
| KAT6A SRX20971022 | Fibroblasts Others | 228 / 10134 (2.2%) | 48 / 101340 (0.0%) | −186.2 | −183.4 | 47.50 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 643 / 10134 (6.3%) | 1384 / 101340 (1.4%) | −183.7 | −180.8 | 4.65 |
| Epitope tags SRX10549776 | K-562 Blood | 980 / 10134 (9.7%) | 3217 / 101340 (3.2%) | −173.7 | −170.9 | 3.05 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 382 / 10134 (3.8%) | 441 / 101340 (0.4%) | −173.0 | −170.2 | 8.66 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1218 / 10134 (12.0%) | 4770 / 101340 (4.7%) | −165.4 | −162.6 | 2.55 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 987 / 10134 (9.7%) | 3388 / 101340 (3.3%) | −163.9 | −161.2 | 2.91 |
| TRP47 SRX4548329 | THP-1 Blood | 1739 / 10134 (17.2%) | 8383 / 101340 (8.3%) | −160.7 | −158.0 | 2.07 |
| TP53 SRX19538272 | U2OS Bone | 435 / 10134 (4.3%) | 694 / 101340 (0.7%) | −159.1 | −156.3 | 6.27 |
| SREBF2 SRX5359048 | HCC70 Breast | 1170 / 10134 (11.5%) | 4646 / 101340 (4.6%) | −154.7 | −152.0 | 2.52 |
| AGO2 SRX6783957 | Hep G2 Liver | 861 / 10134 (8.5%) | 2821 / 101340 (2.8%) | −152.0 | −149.3 | 3.05 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 460 / 10134 (4.5%) | 837 / 101340 (0.8%) | −151.8 | −149.0 | 5.50 |
| AGO2 SRX6783958 | Hep G2 Liver | 856 / 10134 (8.4%) | 2801 / 101340 (2.8%) | −151.6 | −148.8 | 3.06 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1305 / 10134 (12.9%) | 5587 / 101340 (5.5%) | −151.1 | −148.4 | 2.34 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 209 / 10134 (2.1%) | 79 / 101340 (0.1%) | −149.5 | −146.8 | 26.46 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 361 / 10134 (3.6%) | 484 / 101340 (0.5%) | −148.9 | −146.2 | 7.46 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1233 / 10134 (12.2%) | 5160 / 101340 (5.1%) | −148.6 | −145.9 | 2.39 |
| FOXA1 SRX4815198 | MCF-7 Breast | 593 / 10134 (5.9%) | 14453 / 101340 (14.3%) | −147.8 | −145.1 | 0.41 |
| MITF SRX1555436 | 501A Epidermis | 1322 / 10134 (13.0%) | 5793 / 101340 (5.7%) | −146.3 | −143.6 | 2.28 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1286 / 10134 (12.7%) | 5556 / 101340 (5.5%) | −146.2 | −143.5 | 2.31 |
| AR SRX10820653 | LNCAP Prostate | 237 / 10134 (2.3%) | 151 / 101340 (0.1%) | −142.8 | −140.1 | 15.70 |
| RUNX1 SRX2014504 | Jurkat Blood | 1587 / 10134 (15.7%) | 7729 / 101340 (7.6%) | −141.9 | −139.2 | 2.05 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 789 / 10134 (7.8%) | 2568 / 101340 (2.5%) | −140.3 | −137.6 | 3.07 |
| BMI1 SRX7196721 | SF8628 Neural | 1152 / 10134 (11.4%) | 4793 / 101340 (4.7%) | −139.8 | −137.1 | 2.40 |
| FOXA1 SRX4815197 | MCF-7 Breast | 431 / 10134 (4.3%) | 11727 / 101340 (11.6%) | −138.4 | −135.7 | 0.37 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1092 / 10134 (10.8%) | 4436 / 101340 (4.4%) | −138.1 | −135.4 | 2.46 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 451 / 10134 (4.5%) | 903 / 101340 (0.9%) | −137.0 | −134.3 | 4.99 |
| FOXA1 SRX176862 | MCF-7 Breast | 216 / 10134 (2.1%) | 8201 / 101340 (8.1%) | −137.0 | −134.3 | 0.26 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1177 / 10134 (11.6%) | 5046 / 101340 (5.0%) | −134.9 | −132.3 | 2.33 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1043 / 10134 (10.3%) | 4193 / 101340 (4.1%) | −134.1 | −131.4 | 2.49 |
| PBX4 SRX2731658 | PC-3 Prostate | 716 / 10134 (7.1%) | 15639 / 101340 (15.4%) | −133.3 | −130.7 | 0.46 |
| MECOM SRX23677897 | HNT-34 Blood | 1333 / 10134 (13.2%) | 6184 / 101340 (6.1%) | −131.0 | −128.4 | 2.16 |
| MECOM SRX23677896 | HNT-34 Blood | 1374 / 10134 (13.6%) | 6469 / 101340 (6.4%) | −130.9 | −128.3 | 2.12 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1137 / 10134 (11.2%) | 4865 / 101340 (4.8%) | −130.6 | −128.0 | 2.34 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1189 / 10134 (11.7%) | 5224 / 101340 (5.2%) | −129.8 | −127.2 | 2.28 |
| MECOM SRX23677885 | HNT-34 Blood | 1150 / 10134 (11.3%) | 4967 / 101340 (4.9%) | −129.7 | −127.1 | 2.32 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1163 / 10134 (11.5%) | 5098 / 101340 (5.0%) | −127.4 | −124.8 | 2.28 |
| FOXA1 SRX176863 | MCF-7 Breast | 216 / 10134 (2.1%) | 7867 / 101340 (7.8%) | −126.1 | −123.6 | 0.27 |
| STAT5B SRX831881 | CD8+ T cells Blood | 193 / 10134 (1.9%) | 99 / 101340 (0.1%) | −125.8 | −123.2 | 19.49 |
| AR SRX10820651 | LNCAP Prostate | 244 / 10134 (2.4%) | 223 / 101340 (0.2%) | −125.3 | −122.7 | 10.94 |
| FOXA1 SRX3931044 | MCF-7 Breast | 404 / 10134 (4.0%) | 10863 / 101340 (10.7%) | −125.3 | −122.7 | 0.37 |
| MECOM SRX23677884 | HNT-34 Blood | 1115 / 10134 (11.0%) | 4854 / 101340 (4.8%) | −123.6 | −121.0 | 2.30 |
| LARP7 SRX2198835 | HeLa Uterus | 1360 / 10134 (13.4%) | 6535 / 101340 (6.4%) | −123.5 | −121.0 | 2.08 |
| BRD1 SRX286203 | RKO Digestive tract | 745 / 10134 (7.4%) | 2556 / 101340 (2.5%) | −122.4 | −119.9 | 2.91 |
| KAT7 SRX101303 | RKO Digestive tract | 858 / 10134 (8.5%) | 3233 / 101340 (3.2%) | −122.2 | −119.7 | 2.65 |
| Epitope tags SRX2867680 | 293 Kidney | 1327 / 10134 (13.1%) | 6349 / 101340 (6.3%) | −121.6 | −119.1 | 2.09 |
| BMI1 SRX644729 | 293 Kidney | 181 / 10134 (1.8%) | 86 / 101340 (0.1%) | −121.0 | −118.5 | 21.05 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1304 / 10134 (12.9%) | 6224 / 101340 (6.1%) | −119.9 | −117.4 | 2.10 |
| BRPF3 SRX796084 | RKO Digestive tract | 948 / 10134 (9.4%) | 3834 / 101340 (3.8%) | −119.9 | −117.4 | 2.47 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1204 / 10134 (11.9%) | 5548 / 101340 (5.5%) | −119.1 | −116.6 | 2.17 |
| FOXA1 SRX1161177 | MCF-7 Breast | 185 / 10134 (1.8%) | 7092 / 101340 (7.0%) | −118.6 | −116.0 | 0.26 |
| BRPF3 SRX796085 | RKO Digestive tract | 679 / 10134 (6.7%) | 2252 / 101340 (2.2%) | −117.1 | −114.5 | 3.02 |
| LEO1 SRX1873456 | SEM Blood | 939 / 10134 (9.3%) | 3830 / 101340 (3.8%) | −116.9 | −114.4 | 2.45 |
| BRPF3 SRX796086 | RKO Digestive tract | 904 / 10134 (8.9%) | 3613 / 101340 (3.6%) | −116.5 | −114.0 | 2.50 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1054 / 10134 (10.4%) | 4606 / 101340 (4.5%) | −115.6 | −113.0 | 2.29 |
| ESR1 SRX7624157 | MCF-7 Breast | 521 / 10134 (5.1%) | 12206 / 101340 (12.0%) | −115.0 | −112.5 | 0.43 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 368 / 10134 (3.6%) | 723 / 101340 (0.7%) | −113.5 | −111.0 | 5.09 |
| FOXA1 SRX1161176 | MCF-7 Breast | 181 / 10134 (1.8%) | 6855 / 101340 (6.8%) | −113.2 | −110.7 | 0.26 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 447 / 10134 (4.4%) | 11039 / 101340 (10.9%) | −112.4 | −109.9 | 0.40 |
| ESR1 SRX371469 | MCF-7 Breast | 200 / 10134 (2.0%) | 7156 / 101340 (7.1%) | −112.2 | −109.8 | 0.28 |
| FOXA1 SRX371483 | MCF-7 Breast | 220 / 10134 (2.2%) | 7490 / 101340 (7.4%) | −112.0 | −109.5 | 0.29 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 238 / 10134 (2.3%) | 7769 / 101340 (7.7%) | −111.4 | −108.9 | 0.31 |
| FOXA1 SRX1161173 | MCF-7 Breast | 149 / 10134 (1.5%) | 6222 / 101340 (6.1%) | −111.4 | −108.9 | 0.24 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 440 / 10134 (4.3%) | 10897 / 101340 (10.8%) | −111.3 | −108.8 | 0.40 |
| TET2 SRX2014505 | Jurkat Blood | 1617 / 10134 (16.0%) | 8740 / 101340 (8.6%) | −110.8 | −108.3 | 1.85 |
| MethylCap SRX014767 | NB-4 Blood | 1081 / 10134 (10.7%) | 4887 / 101340 (4.8%) | −110.7 | −108.2 | 2.21 |
| ESR1 SRX4367193 | MCF-7 Breast | 668 / 10134 (6.6%) | 14068 / 101340 (13.9%) | −110.2 | −107.8 | 0.47 |
| ERG SRX063922 | K-562 Blood | 987 / 10134 (9.7%) | 4281 / 101340 (4.2%) | −109.4 | −106.9 | 2.31 |
| GFP SRX12567758 | MRC-5 Lung | 953 / 10134 (9.4%) | 4067 / 101340 (4.0%) | −108.9 | −106.5 | 2.34 |
| ESR1 SRX371471 | ZR-75-1 Breast | 218 / 10134 (2.2%) | 7344 / 101340 (7.2%) | −108.6 | −106.2 | 0.30 |
| FOXA1 SRX371481 | MCF-7 Breast | 213 / 10134 (2.1%) | 7260 / 101340 (7.2%) | −108.6 | −106.2 | 0.29 |
| ESR1 SRX371478 | MCF-7 Breast | 263 / 10134 (2.6%) | 8076 / 101340 (8.0%) | −108.3 | −105.9 | 0.33 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 242 / 10134 (2.4%) | 7720 / 101340 (7.6%) | −107.9 | −105.5 | 0.31 |
| ESR1 SRX371470 | ZR-75-1 Breast | 179 / 10134 (1.8%) | 6649 / 101340 (6.6%) | −107.8 | −105.4 | 0.27 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 192 / 10134 (1.9%) | 6862 / 101340 (6.8%) | −107.4 | −105.0 | 0.28 |
| ATF3 SRX2207918 | CS1AN Epidermis | 1407 / 10134 (13.9%) | 7278 / 101340 (7.2%) | −107.1 | −104.7 | 1.93 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 569 / 10134 (5.6%) | 1769 / 101340 (1.7%) | −107.0 | −104.5 | 3.22 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 180 / 10134 (1.8%) | 6638 / 101340 (6.6%) | −106.9 | −104.5 | 0.27 |
| FOXA1 SRX371482 | MCF-7 Breast | 296 / 10134 (2.9%) | 8558 / 101340 (8.4%) | −106.9 | −104.5 | 0.35 |
| GATA3 SRX190239 | MCF-7 Breast | 309 / 10134 (3.0%) | 8756 / 101340 (8.6%) | −106.8 | −104.4 | 0.35 |
| NFYB SRX16608147 | HeLa Uterus | 186 / 10134 (1.8%) | 134 / 101340 (0.1%) | −106.7 | −104.2 | 13.88 |
| ING5 SRX286202 | RKO Digestive tract | 816 / 10134 (8.1%) | 3234 / 101340 (3.2%) | −106.4 | −103.9 | 2.52 |
| SSRP1 SRX3436567 | HT-1080 Bone | 264 / 10134 (2.6%) | 369 / 101340 (0.4%) | −105.9 | −103.5 | 7.15 |
| GATA3 SRX176864 | MCF-7 Breast | 139 / 10134 (1.4%) | 5864 / 101340 (5.8%) | −105.7 | −103.3 | 0.24 |
| ESR1 SRX20282961 | MCF-7 Breast | 262 / 10134 (2.6%) | 7968 / 101340 (7.9%) | −105.5 | −103.1 | 0.33 |
| CDK9 SRX7366783 | MCF-7 Breast | 166 / 10134 (1.6%) | 93 / 101340 (0.1%) | −105.0 | −102.6 | 17.85 |
| ESR1 SRX7624156 | MCF-7 Breast | 336 / 10134 (3.3%) | 9104 / 101340 (9.0%) | −104.8 | −102.4 | 0.37 |
| TP53 SRX396254 | Fibroblasts Others | 548 / 10134 (5.4%) | 1682 / 101340 (1.7%) | −104.7 | −102.3 | 3.26 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 516 / 10134 (5.1%) | 1517 / 101340 (1.5%) | −104.2 | −101.8 | 3.40 |
| FOXA1 SRX1787653 | MCF-7 Breast | 156 / 10134 (1.5%) | 6124 / 101340 (6.0%) | −104.0 | −101.6 | 0.25 |
| MEAF6 DRX234811 | 293 Kidney | 1033 / 10134 (10.2%) | 4702 / 101340 (4.6%) | −103.8 | −101.4 | 2.20 |
| MECOM SRX23677890 | HNT-34 Blood | 1109 / 10134 (10.9%) | 5231 / 101340 (5.2%) | −103.7 | −101.3 | 2.12 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 775 / 10134 (7.6%) | 3026 / 101340 (3.0%) | −103.5 | −101.2 | 2.56 |
| FOXA1 SRX1161175 | MCF-7 Breast | 148 / 10134 (1.5%) | 5955 / 101340 (5.9%) | −103.3 | −100.9 | 0.25 |
| GFP SRX12567763 | MRC-5 Lung | 1038 / 10134 (10.2%) | 4757 / 101340 (4.7%) | −102.9 | −100.6 | 2.18 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 187 / 10134 (1.8%) | 6628 / 101340 (6.5%) | −102.7 | −100.3 | 0.28 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 487 / 10134 (4.8%) | 1383 / 101340 (1.4%) | −102.6 | −100.3 | 3.52 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 329 / 10134 (3.2%) | 639 / 101340 (0.6%) | −102.5 | −100.1 | 5.15 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 342 / 10134 (3.4%) | 9114 / 101340 (9.0%) | −102.4 | −100.1 | 0.38 |
| RORC SRX5359052 | HCC70 Breast | 797 / 10134 (7.9%) | 3185 / 101340 (3.1%) | −102.2 | −99.8 | 2.50 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 1123 / 10134 (11.1%) | 5366 / 101340 (5.3%) | −102.0 | −99.6 | 2.09 |
| ERG SRX063921 | K-562 Blood | 924 / 10134 (9.1%) | 4012 / 101340 (4.0%) | −101.9 | −99.6 | 2.30 |
| GRHL3 SRX2582162 | NHEK Epidermis | 665 / 10134 (6.6%) | 2383 / 101340 (2.4%) | −101.9 | −99.6 | 2.79 |
| MECOM SRX23677891 | HNT-34 Blood | 1103 / 10134 (10.9%) | 5234 / 101340 (5.2%) | −101.5 | −99.2 | 2.11 |
| ZFX SRX7805372 | 293 Kidney | 970 / 10134 (9.6%) | 4332 / 101340 (4.3%) | −101.2 | −98.9 | 2.24 |
| Epitope tags SRX2255894 | 293 Kidney | 836 / 10134 (8.2%) | 3457 / 101340 (3.4%) | −101.0 | −98.6 | 2.42 |
| MEAF6 DRX300417 | 293 Kidney | 939 / 10134 (9.3%) | 4130 / 101340 (4.1%) | −101.0 | −98.6 | 2.27 |
| ESR1 SRX176860 | MCF-7 Breast | 353 / 10134 (3.5%) | 9197 / 101340 (9.1%) | −100.2 | −97.9 | 0.38 |
| ESR1 SRX1531791 | MCF-7 Breast | 200 / 10134 (2.0%) | 6769 / 101340 (6.7%) | −100.2 | −97.9 | 0.30 |
| RORC SRX5359053 | HCC70 Breast | 771 / 10134 (7.6%) | 3058 / 101340 (3.0%) | −100.1 | −97.8 | 2.52 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 187 / 10134 (1.8%) | 6530 / 101340 (6.4%) | −99.6 | −97.3 | 0.29 |
| Epitope tags SRX10549778 | K-562 Blood | 694 / 10134 (6.8%) | 2590 / 101340 (2.6%) | −99.6 | −97.3 | 2.68 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 371 / 10134 (3.7%) | 9436 / 101340 (9.3%) | −99.3 | −97.0 | 0.39 |
| NABP2 SRX9523535 | HT-1080 Bone | 854 / 10134 (8.4%) | 3605 / 101340 (3.6%) | −99.2 | −96.9 | 2.37 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 143 / 10134 (1.4%) | 5739 / 101340 (5.7%) | −99.1 | −96.8 | 0.25 |
| ESR1 SRX194572 | MCF-7 Breast | 128 / 10134 (1.3%) | 5452 / 101340 (5.4%) | −98.8 | −96.5 | 0.23 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 316 / 10134 (3.1%) | 8578 / 101340 (8.5%) | −98.6 | −96.3 | 0.37 |
| FOXA1 SRX3923514 | MCF-7 Breast | 213 / 10134 (2.1%) | 6928 / 101340 (6.8%) | −98.4 | −96.1 | 0.31 |
| ESR1 SRX194569 | MCF-7 Breast | 221 / 10134 (2.2%) | 7049 / 101340 (7.0%) | −98.1 | −95.8 | 0.31 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 169 / 10134 (1.7%) | 6167 / 101340 (6.1%) | −98.0 | −95.7 | 0.27 |
| ESR1 SRX20282960 | MCF-7 Breast | 249 / 10134 (2.5%) | 7491 / 101340 (7.4%) | −97.6 | −95.3 | 0.33 |
| RBFOX2 SRX4708082 | K-562 Blood | 1431 / 10134 (14.1%) | 7726 / 101340 (7.6%) | −97.1 | −94.9 | 1.85 |
| ESR1 SRX371467 | MCF-7 Breast | 226 / 10134 (2.2%) | 7099 / 101340 (7.0%) | −97.1 | −94.8 | 0.32 |
| FOXA2 SRX100448 | Hep G2 Liver | 238 / 10134 (2.3%) | 7290 / 101340 (7.2%) | −97.0 | −94.7 | 0.33 |
| CDK9 SRX7366781 | MCF-7 Breast | 156 / 10134 (1.5%) | 93 / 101340 (0.1%) | −96.5 | −94.2 | 16.77 |
| TLE3 SRX4815191 | MCF-7 Breast | 217 / 10134 (2.1%) | 6929 / 101340 (6.8%) | −96.4 | −94.1 | 0.31 |
| GATA3 SRX5057632 | MCF-7 Breast | 135 / 10134 (1.3%) | 5504 / 101340 (5.4%) | −96.2 | −93.9 | 0.25 |
| FOXA1 SRX11222437 | MCF-7 Breast | 146 / 10134 (1.4%) | 5699 / 101340 (5.6%) | −96.1 | −93.8 | 0.26 |
| RAC1 SRX10365541 | MCF-7 Breast | 107 / 10134 (1.1%) | 4972 / 101340 (4.9%) | −96.0 | −93.8 | 0.22 |
| FOXA1 SRX100506 | Hep G2 Liver | 290 / 10134 (2.9%) | 8081 / 101340 (8.0%) | −96.0 | −93.7 | 0.36 |
| ESR1 SRX371468 | MCF-7 Breast | 134 / 10134 (1.3%) | 5479 / 101340 (5.4%) | −96.0 | −93.7 | 0.24 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 334 / 10134 (3.3%) | 8736 / 101340 (8.6%) | −95.5 | −93.2 | 0.38 |
| CHD6 SRX17709200 | C4-2 Prostate | 947 / 10134 (9.3%) | 4297 / 101340 (4.2%) | −95.4 | −93.1 | 2.20 |
| FOXA1 SRX1161174 | MCF-7 Breast | 224 / 10134 (2.2%) | 7005 / 101340 (6.9%) | −95.3 | −93.0 | 0.32 |
| FOS SRX150477 | MCF 10A Breast | 534 / 10134 (5.3%) | 11613 / 101340 (11.5%) | −95.2 | −92.9 | 0.46 |
| FOXA1 SRX028634 | MCF-7 Breast | 96 / 10134 (0.9%) | 4735 / 101340 (4.7%) | −95.1 | −92.9 | 0.20 |
| ESR1 SRX10365536 | MCF-7 Breast | 107 / 10134 (1.1%) | 4945 / 101340 (4.9%) | −95.1 | −92.9 | 0.22 |
| ESR1 SRX20282939 | MCF-7 Breast | 255 / 10134 (2.5%) | 7497 / 101340 (7.4%) | −95.1 | −92.8 | 0.34 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 277 / 10134 (2.7%) | 7827 / 101340 (7.7%) | −94.5 | −92.3 | 0.35 |
| MethylCap SRX014766 | NB-4 Blood | 951 / 10134 (9.4%) | 4348 / 101340 (4.3%) | −94.4 | −92.1 | 2.19 |
| FOXA1 SRX100454 | T-47D Breast | 298 / 10134 (2.9%) | 8129 / 101340 (8.0%) | −93.8 | −91.5 | 0.37 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 171 / 10134 (1.7%) | 6064 / 101340 (6.0%) | −93.7 | −91.5 | 0.28 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 288 / 10134 (2.8%) | 7971 / 101340 (7.9%) | −93.7 | −91.5 | 0.36 |
| FOXA1 SRX1787651 | MCF-7 Breast | 110 / 10134 (1.1%) | 4960 / 101340 (4.9%) | −93.6 | −91.4 | 0.22 |
| Epitope tags SRX10549777 | K-562 Blood | 1445 / 10134 (14.3%) | 7945 / 101340 (7.8%) | −93.1 | −90.9 | 1.82 |
| ESR1 SRX176861 | MCF-7 Breast | 373 / 10134 (3.7%) | 9234 / 101340 (9.1%) | −93.1 | −90.8 | 0.40 |
| FOXA1 SRX371480 | MCF-7 Breast | 149 / 10134 (1.5%) | 5655 / 101340 (5.6%) | −93.0 | −90.8 | 0.26 |
| ESR1 SRX371476 | MCF-7 Breast | 165 / 10134 (1.6%) | 5926 / 101340 (5.8%) | −92.7 | −90.4 | 0.28 |
| Crotonyllysine SRX12306536 | Polycystic kidney Kidney | 941 / 10134 (9.3%) | 4321 / 101340 (4.3%) | −92.4 | −90.2 | 2.18 |
| FOXA1 SRX1787652 | MCF-7 Breast | 124 / 10134 (1.2%) | 5185 / 101340 (5.1%) | −92.3 | −90.1 | 0.24 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 223 / 10134 (2.2%) | 6887 / 101340 (6.8%) | −92.2 | −90.0 | 0.32 |
| FOXA1 SRX3931043 | MCF-7 Breast | 227 / 10134 (2.2%) | 6951 / 101340 (6.9%) | −92.2 | −90.0 | 0.33 |
| FOXA1 SRX11222441 | MCF-7 Breast | 167 / 10134 (1.6%) | 5936 / 101340 (5.9%) | −91.9 | −89.6 | 0.28 |
| RAC1 SRX10365543 | MCF-7 Breast | 112 / 10134 (1.1%) | 4928 / 101340 (4.9%) | −91.3 | −89.1 | 0.23 |
| FOXA1 SRX1787655 | MCF-7 Breast | 103 / 10134 (1.0%) | 4753 / 101340 (4.7%) | −91.2 | −89.0 | 0.22 |
| FOS SRX150478 | MCF 10A Breast | 571 / 10134 (5.6%) | 11962 / 101340 (11.8%) | −91.2 | −89.0 | 0.48 |
| FOXA1 SRX028635 | MCF-7 Breast | 101 / 10134 (1.0%) | 4712 / 101340 (4.6%) | −91.1 | −88.9 | 0.21 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 100 / 10134 (1.0%) | 4689 / 101340 (4.6%) | −91.0 | −88.8 | 0.21 |
| FOXA1 SRX3923517 | MCF-7 Breast | 150 / 10134 (1.5%) | 5605 / 101340 (5.5%) | −90.9 | −88.7 | 0.27 |
| ESR1 SRX371479 | MCF-7 Breast | 213 / 10134 (2.1%) | 6673 / 101340 (6.6%) | −90.7 | −88.5 | 0.32 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 935 / 10134 (9.2%) | 4332 / 101340 (4.3%) | −90.1 | −87.9 | 2.16 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 404 / 10134 (4.0%) | 1095 / 101340 (1.1%) | −89.9 | −87.7 | 3.69 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 660 / 10134 (6.5%) | 2540 / 101340 (2.5%) | −89.9 | −87.7 | 2.60 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 135 / 10134 (1.3%) | 66 / 101340 (0.1%) | −89.6 | −87.4 | 20.45 |
| FOXA1 SRX219284 | LNCAP Prostate | 300 / 10134 (3.0%) | 8004 / 101340 (7.9%) | −89.6 | −87.4 | 0.37 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 244 / 10134 (2.4%) | 7132 / 101340 (7.0%) | −89.6 | −87.4 | 0.34 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 230 / 10134 (2.3%) | 6906 / 101340 (6.8%) | −89.5 | −87.3 | 0.33 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 451 / 10134 (4.5%) | 1343 / 101340 (1.3%) | −89.5 | −87.3 | 3.36 |
| FOXA1 SRX5323843 | MCF-7 Breast | 108 / 10134 (1.1%) | 4790 / 101340 (4.7%) | −89.2 | −87.1 | 0.23 |
| ESR1 SRX2943591 | MCF-7 Breast | 155 / 10134 (1.5%) | 5640 / 101340 (5.6%) | −89.2 | −87.0 | 0.27 |
| ARID1A SRX5089376 | MCF-7 Breast | 196 / 10134 (1.9%) | 6336 / 101340 (6.3%) | −89.1 | −86.9 | 0.31 |
| ESR1 SRX10365532 | MCF-7 Breast | 115 / 10134 (1.1%) | 4912 / 101340 (4.8%) | −89.0 | −86.8 | 0.23 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1134 / 10134 (11.2%) | 5762 / 101340 (5.7%) | −88.8 | −86.6 | 1.97 |
| TET2 SRX1427029 | 293 Kidney | 774 / 10134 (7.6%) | 3284 / 101340 (3.2%) | −88.7 | −86.5 | 2.36 |
| Epitope tags DRX443510 | 293 Kidney | 859 / 10134 (8.5%) | 3847 / 101340 (3.8%) | −88.6 | −86.4 | 2.23 |
| ESR1 SRX4451213 | MCF-7 Breast | 230 / 10134 (2.3%) | 6872 / 101340 (6.8%) | −88.6 | −86.4 | 0.33 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 802 / 10134 (7.9%) | 3473 / 101340 (3.4%) | −88.5 | −86.3 | 2.31 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 296 / 10134 (2.9%) | 603 / 101340 (0.6%) | −88.4 | −86.2 | 4.91 |
| FOXA1 SRX3931055 | MCF-7 Breast | 192 / 10134 (1.9%) | 6242 / 101340 (6.2%) | −88.2 | −86.1 | 0.31 |
| CHD6 SRX17709201 | C4-2 Prostate | 900 / 10134 (8.9%) | 4136 / 101340 (4.1%) | −88.1 | −86.0 | 2.18 |
| BRD2 SRX8090652 | Synoviocytes Others | 712 / 10134 (7.0%) | 2906 / 101340 (2.9%) | −87.6 | −85.4 | 2.45 |
| FOXA1 SRX3923516 | MCF-7 Breast | 160 / 10134 (1.6%) | 5669 / 101340 (5.6%) | −87.4 | −85.2 | 0.28 |
| TLE3 SRX4815192 | MCF-7 Breast | 210 / 10134 (2.1%) | 6507 / 101340 (6.4%) | −87.3 | −85.2 | 0.32 |
| FOXA2 SRX3230382 | Hep G2 Liver | 315 / 10134 (3.1%) | 8151 / 101340 (8.0%) | −87.3 | −85.1 | 0.39 |
| ESR1 SRX20282954 | MCF-7 Breast | 253 / 10134 (2.5%) | 7194 / 101340 (7.1%) | −87.2 | −85.1 | 0.35 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 213 / 10134 (2.1%) | 6541 / 101340 (6.5%) | −86.9 | −84.7 | 0.33 |
| FOXA1 SRX1961158 | T-47D Breast | 226 / 10134 (2.2%) | 6745 / 101340 (6.7%) | −86.7 | −84.6 | 0.34 |
| FOXA1 SRX1161203 | T-47D Breast | 165 / 10134 (1.6%) | 5733 / 101340 (5.7%) | −86.6 | −84.5 | 0.29 |
| Epitope tags SRX14024876 | Mesenchymal stem cells Others | 1319 / 10134 (13.0%) | 7189 / 101340 (7.1%) | −86.5 | −84.4 | 1.83 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 839 / 10134 (8.3%) | 3761 / 101340 (3.7%) | −86.3 | −84.2 | 2.23 |
| Epitope tags SRX12024485 | Polycystic kidney Kidney | 1539 / 10134 (15.2%) | 8890 / 101340 (8.8%) | −85.9 | −83.8 | 1.73 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 142 / 10134 (1.4%) | 90 / 101340 (0.1%) | −85.9 | −83.8 | 15.78 |
| GRHL3 SRX2582161 | NHEK Epidermis | 539 / 10134 (5.3%) | 1881 / 101340 (1.9%) | −85.7 | −83.6 | 2.87 |
| GATA3 SRX6712581 | MCF-7 Breast | 191 / 10134 (1.9%) | 6142 / 101340 (6.1%) | −85.7 | −83.6 | 0.31 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 217 / 10134 (2.1%) | 6556 / 101340 (6.5%) | −85.4 | −83.3 | 0.33 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 188 / 10134 (1.9%) | 6075 / 101340 (6.0%) | −85.2 | −83.1 | 0.31 |
| FOXA1 SRX1961157 | T-47D Breast | 252 / 10134 (2.5%) | 7100 / 101340 (7.0%) | −85.0 | −82.8 | 0.35 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 107 / 10134 (1.1%) | 4643 / 101340 (4.6%) | −84.9 | −82.8 | 0.23 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 133 / 10134 (1.3%) | 73 / 101340 (0.1%) | −84.9 | −82.8 | 18.22 |
| ESR1 SRX371477 | MCF-7 Breast | 114 / 10134 (1.1%) | 4770 / 101340 (4.7%) | −84.8 | −82.7 | 0.24 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 352 / 10134 (3.5%) | 889 / 101340 (0.9%) | −84.8 | −82.7 | 3.96 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 1079 / 10134 (10.6%) | 5474 / 101340 (5.4%) | −84.6 | −82.5 | 1.97 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 980 / 10134 (9.7%) | 4770 / 101340 (4.7%) | −84.6 | −82.5 | 2.05 |
| ESR1 SRX20282972 | MCF-7 Breast | 267 / 10134 (2.6%) | 7316 / 101340 (7.2%) | −84.5 | −82.3 | 0.36 |
| ESR1 SRX10365533 | MCF-7 Breast | 104 / 10134 (1.0%) | 4569 / 101340 (4.5%) | −84.5 | −82.3 | 0.23 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 727 / 10134 (7.2%) | 3065 / 101340 (3.0%) | −84.1 | −82.0 | 2.37 |
| ESR1 SRX4451212 | MCF-7 Breast | 221 / 10134 (2.2%) | 6563 / 101340 (6.5%) | −83.8 | −81.6 | 0.34 |
| ESR1 SRX371474 | BT-474 Breast | 102 / 10134 (1.0%) | 4511 / 101340 (4.5%) | −83.7 | −81.6 | 0.23 |
| CXXC1 SRX1424886 | SEM Blood | 847 / 10134 (8.4%) | 3879 / 101340 (3.8%) | −83.3 | −81.2 | 2.18 |
| AR SRX9469988 | LAPC-4 Prostate | 322 / 10134 (3.2%) | 8107 / 101340 (8.0%) | −83.3 | −81.2 | 0.40 |
| FOXA1 SRX5203303 | MCF-7 Breast | 72 / 10134 (0.7%) | 3906 / 101340 (3.9%) | −83.2 | −81.1 | 0.18 |
| CBFB SRX265218 | ME-1 Blood | 856 / 10134 (8.4%) | 3942 / 101340 (3.9%) | −83.2 | −81.1 | 2.17 |
| FOXA1 SRX11222438 | MCF-7 Breast | 122 / 10134 (1.2%) | 4853 / 101340 (4.8%) | −82.8 | −80.7 | 0.25 |
| Epitope tags SRX7276677 | 293 Kidney | 1540 / 10134 (15.2%) | 9006 / 101340 (8.9%) | −82.7 | −80.6 | 1.71 |
| FOXA1 SRX3923518 | MCF-7 Breast | 158 / 10134 (1.6%) | 5479 / 101340 (5.4%) | −82.6 | −80.5 | 0.29 |
| ESR1 SRX10365535 | MCF-7 Breast | 194 / 10134 (1.9%) | 6086 / 101340 (6.0%) | −82.6 | −80.5 | 0.32 |
| CTCF SRX13551281 | Adipose stem cells Adipocyte | 1738 / 10134 (17.2%) | 10585 / 101340 (10.4%) | −82.4 | −80.3 | 1.64 |
| FOXA1 SRX3931054 | MCF-7 Breast | 225 / 10134 (2.2%) | 6573 / 101340 (6.5%) | −82.2 | −80.1 | 0.34 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 79 / 10134 (0.8%) | 4016 / 101340 (4.0%) | −82.0 | −80.0 | 0.20 |
| FOXA1 SRX1447317 | MCF-7 Breast | 156 / 10134 (1.5%) | 5424 / 101340 (5.4%) | −82.0 | −79.9 | 0.29 |
| ESR1 SRX330067 | MCF-7 Breast | 213 / 10134 (2.1%) | 6368 / 101340 (6.3%) | −81.8 | −79.7 | 0.33 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 217 / 10134 (2.1%) | 6428 / 101340 (6.3%) | −81.8 | −79.7 | 0.34 |
| FOXA1 SRX3923519 | MCF-7 Breast | 139 / 10134 (1.4%) | 5122 / 101340 (5.1%) | −81.7 | −79.6 | 0.27 |
| FOXA1 SRX3931033 | MCF-7 Breast | 150 / 10134 (1.5%) | 5314 / 101340 (5.2%) | −81.6 | −79.6 | 0.28 |
| ESR1 SRX371475 | BT-474 Breast | 117 / 10134 (1.2%) | 4716 / 101340 (4.7%) | −81.4 | −79.3 | 0.25 |
| FOXA1 SRX5203307 | MCF-7 Breast | 62 / 10134 (0.6%) | 3644 / 101340 (3.6%) | −81.4 | −79.3 | 0.17 |
| FOXA1 SRX3931032 | MCF-7 Breast | 139 / 10134 (1.4%) | 5109 / 101340 (5.0%) | −81.3 | −79.2 | 0.27 |
| FOXA1 SRX9604647 | LNCAP Prostate | 357 / 10134 (3.5%) | 8546 / 101340 (8.4%) | −81.2 | −79.2 | 0.42 |
| ESR1 SRX2943589 | MCF-7 Breast | 120 / 10134 (1.2%) | 4766 / 101340 (4.7%) | −81.2 | −79.1 | 0.25 |
| CDK9 SRX20230567 | Ishikawa Uterus | 1016 / 10134 (10.0%) | 5111 / 101340 (5.0%) | −81.0 | −79.0 | 1.99 |
| ESR1 SRX330070 | MCF-7 Breast | 117 / 10134 (1.2%) | 4698 / 101340 (4.6%) | −80.8 | −78.7 | 0.25 |
| EP300 SRX1012648 | MCF-7 Breast | 113 / 10134 (1.1%) | 4624 / 101340 (4.6%) | −80.8 | −78.7 | 0.24 |
| FOXA1 SRX3923515 | MCF-7 Breast | 132 / 10134 (1.3%) | 4969 / 101340 (4.9%) | −80.8 | −78.7 | 0.27 |
| FOXA1 SRX11222442 | MCF-7 Breast | 160 / 10134 (1.6%) | 5451 / 101340 (5.4%) | −80.7 | −78.6 | 0.29 |
| ESR1 SRX20282946 | MCF-7 Breast | 143 / 10134 (1.4%) | 5156 / 101340 (5.1%) | −80.7 | −78.6 | 0.28 |
| FOXA1 SRX6860635 | T-47D Breast | 181 / 10134 (1.8%) | 5807 / 101340 (5.7%) | −80.7 | −78.6 | 0.31 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 68 / 10134 (0.7%) | 3748 / 101340 (3.7%) | −80.7 | −78.6 | 0.18 |
| PHF6 SRX11508321 | G-401 Kidney | 888 / 10134 (8.8%) | 4222 / 101340 (4.2%) | −80.6 | −78.5 | 2.10 |
| FOXA1 SRX6878603 | LNCAP Prostate | 267 / 10134 (2.6%) | 7174 / 101340 (7.1%) | −80.5 | −78.5 | 0.37 |
| ESR1 SRX8537722 | MCF-7 Breast | 224 / 10134 (2.2%) | 6497 / 101340 (6.4%) | −80.5 | −78.4 | 0.34 |
| CDK9 SRX20230574 | Ishikawa Uterus | 862 / 10134 (8.5%) | 4043 / 101340 (4.0%) | −80.4 | −78.4 | 2.13 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 159 / 10134 (1.6%) | 5422 / 101340 (5.4%) | −80.3 | −78.3 | 0.29 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 162 / 10134 (1.6%) | 5470 / 101340 (5.4%) | −80.2 | −78.2 | 0.30 |
| EP300 SRX176885 | MCF-7 Breast | 122 / 10134 (1.2%) | 4769 / 101340 (4.7%) | −80.2 | −78.1 | 0.26 |
| FOXA1 SRX15430999 | T-47D Breast | 270 / 10134 (2.7%) | 7205 / 101340 (7.1%) | −80.2 | −78.1 | 0.37 |
| FOXA1 SRX5323846 | MCF-7 Breast | 85 / 10134 (0.8%) | 4078 / 101340 (4.0%) | −80.2 | −78.1 | 0.21 |
| GATA3 SRX5457550 | MCF-7 Breast | 274 / 10134 (2.7%) | 7258 / 101340 (7.2%) | −79.9 | −77.9 | 0.38 |
| SSRP1 SRX3436566 | HT-1080 Bone | 186 / 10134 (1.8%) | 235 / 101340 (0.2%) | −79.8 | −77.8 | 7.91 |
| ESR1 SRX20282955 | MCF-7 Breast | 257 / 10134 (2.5%) | 6987 / 101340 (6.9%) | −79.7 | −77.7 | 0.37 |
| FOXA1 SRX1447316 | MCF-7 Breast | 100 / 10134 (1.0%) | 4351 / 101340 (4.3%) | −79.7 | −77.6 | 0.23 |
| ESR1 SRX1012632 | MCF-7 Breast | 115 / 10134 (1.1%) | 4626 / 101340 (4.6%) | −79.6 | −77.5 | 0.25 |
| FOXA1 SRX5323845 | MCF-7 Breast | 85 / 10134 (0.8%) | 4060 / 101340 (4.0%) | −79.6 | −77.5 | 0.21 |
| KMT2A SRX2323891 | 293 Kidney | 565 / 10134 (5.6%) | 2129 / 101340 (2.1%) | −79.5 | −77.5 | 2.65 |
| FOXA1 SRX1787654 | MCF-7 Breast | 84 / 10134 (0.8%) | 4038 / 101340 (4.0%) | −79.5 | −77.5 | 0.21 |
| FOXA1 SRX9604645 | LNCAP Prostate | 340 / 10134 (3.4%) | 8230 / 101340 (8.1%) | −79.5 | −77.4 | 0.41 |
| ESR1 SRX792933 | LY2 Breast | 195 / 10134 (1.9%) | 5992 / 101340 (5.9%) | −79.4 | −77.4 | 0.33 |
| FOXA1 SRX2017929 | LNCAP Prostate | 319 / 10134 (3.1%) | 7910 / 101340 (7.8%) | −79.3 | −77.3 | 0.40 |
| EP300 SRX1012644 | MCF-7 Breast | 105 / 10134 (1.0%) | 4426 / 101340 (4.4%) | −79.1 | −77.1 | 0.24 |
| FOS SRX4192880 | MCF 10A Breast | 427 / 10134 (4.2%) | 9463 / 101340 (9.3%) | −79.0 | −77.0 | 0.45 |
| ESR1 SRX10365558 | MCF-7 Breast | 160 / 10134 (1.6%) | 5397 / 101340 (5.3%) | −79.0 | −77.0 | 0.30 |
| CDK9 SRX20230570 | Ishikawa Uterus | 973 / 10134 (9.6%) | 4855 / 101340 (4.8%) | −79.0 | −76.9 | 2.00 |
| FOXA1 SRX3923511 | MCF-7 Breast | 86 / 10134 (0.8%) | 4058 / 101340 (4.0%) | −78.8 | −76.8 | 0.21 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 359 / 10134 (3.5%) | 8477 / 101340 (8.4%) | −78.7 | −76.7 | 0.42 |
| NCOA3 SRX4663589 | MCF-7 Breast | 63 / 10134 (0.6%) | 3588 / 101340 (3.5%) | −78.7 | −76.7 | 0.18 |
| SREBF2 SRX5359049 | HCC70 Breast | 683 / 10134 (6.7%) | 2888 / 101340 (2.8%) | −78.5 | −76.5 | 2.36 |
| ARID1A SRX5089379 | MCF-7 Breast | 244 / 10134 (2.4%) | 6741 / 101340 (6.7%) | −78.5 | −76.5 | 0.36 |
| FOXA1 SRX3931056 | MCF-7 Breast | 147 / 10134 (1.5%) | 5143 / 101340 (5.1%) | −78.1 | −76.1 | 0.29 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 915 / 10134 (9.0%) | 4472 / 101340 (4.4%) | −77.9 | −75.9 | 2.05 |
| FOXA1 SRX5203294 | MCF-7 Breast | 66 / 10134 (0.7%) | 3625 / 101340 (3.6%) | −77.8 | −75.8 | 0.18 |
| FOXA1 SRX5323829 | T-47D Breast | 139 / 10134 (1.4%) | 4993 / 101340 (4.9%) | −77.7 | −75.7 | 0.28 |
| SUZ12 SRX10184494 | K-562 Blood | 1427 / 10134 (14.1%) | 8293 / 101340 (8.2%) | −77.6 | −75.6 | 1.72 |
| PGR SRX1012655 | MCF-7 Breast | 160 / 10134 (1.6%) | 5352 / 101340 (5.3%) | −77.6 | −75.6 | 0.30 |
| FOXA1 SRX219285 | LNCAP Prostate | 226 / 10134 (2.2%) | 6425 / 101340 (6.3%) | −77.6 | −75.5 | 0.35 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 66 / 10134 (0.7%) | 3620 / 101340 (3.6%) | −77.5 | −75.5 | 0.18 |
| KMT2A SRX2281249 | SEM Blood | 1108 / 10134 (10.9%) | 5877 / 101340 (5.8%) | −77.4 | −75.4 | 1.89 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 175 / 10134 (1.7%) | 211 / 101340 (0.2%) | −77.3 | −75.3 | 8.29 |
| NR3C1 SRX19024866 | MCF-7 Breast | 82 / 10134 (0.8%) | 3928 / 101340 (3.9%) | −77.1 | −75.1 | 0.21 |
| ESR1 SRX330069 | MCF-7 Breast | 148 / 10134 (1.5%) | 5126 / 101340 (5.1%) | −77.0 | −75.0 | 0.29 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 703 / 10134 (6.9%) | 3049 / 101340 (3.0%) | −77.0 | −75.0 | 2.31 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 166 / 10134 (1.6%) | 5428 / 101340 (5.4%) | −76.9 | −74.9 | 0.31 |
| FOXA1 SRX100477 | Hep G2 Liver | 288 / 10134 (2.8%) | 7354 / 101340 (7.3%) | −76.8 | −74.8 | 0.39 |
| ETS1 SRX3033231 | HEYA8 Gonad | 181 / 10134 (1.8%) | 233 / 101340 (0.2%) | −76.8 | −74.8 | 7.77 |
| FOXA1 SRX497612 | VCaP Prostate | 234 / 10134 (2.3%) | 6523 / 101340 (6.4%) | −76.8 | −74.8 | 0.36 |
| ESR1 SRX3123829 | MCF-7 Breast | 139 / 10134 (1.4%) | 4958 / 101340 (4.9%) | −76.5 | −74.5 | 0.28 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 240 / 10134 (2.4%) | 6609 / 101340 (6.5%) | −76.5 | −74.5 | 0.36 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 335 / 10134 (3.3%) | 890 / 101340 (0.9%) | −76.2 | −74.2 | 3.76 |
| ESR1 SRX2881000 | MCF-7 Breast | 221 / 10134 (2.2%) | 6296 / 101340 (6.2%) | −76.1 | −74.1 | 0.35 |
| ESR1 SRX2912055 | MCF-7 Breast | 91 / 10134 (0.9%) | 4069 / 101340 (4.0%) | −76.1 | −74.1 | 0.22 |
| ESR1 SRX3110725 | MCF-7 Breast | 224 / 10134 (2.2%) | 6336 / 101340 (6.3%) | −76.0 | −74.0 | 0.35 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 218 / 10134 (2.2%) | 6239 / 101340 (6.2%) | −75.9 | −73.9 | 0.35 |
| CTCF SRX12008351 | MCF 10A Breast | 1654 / 10134 (16.3%) | 10153 / 101340 (10.0%) | −75.8 | −73.9 | 1.63 |
| ESR1 SRX330068 | MCF-7 Breast | 114 / 10134 (1.1%) | 4492 / 101340 (4.4%) | −75.8 | −73.8 | 0.25 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 204 / 10134 (2.0%) | 6009 / 101340 (5.9%) | −75.7 | −73.7 | 0.34 |
| FOXA1 SRX1885185 | LNCAP Prostate | 185 / 10134 (1.8%) | 5702 / 101340 (5.6%) | −75.6 | −73.6 | 0.32 |
| AR SRX10365514 | MCF-7 Breast | 51 / 10134 (0.5%) | 3241 / 101340 (3.2%) | −75.3 | −73.4 | 0.16 |
| FOXA1 SRX1885184 | LNCAP Prostate | 232 / 10134 (2.3%) | 6437 / 101340 (6.4%) | −75.3 | −73.3 | 0.36 |
| NR2F2 SRX190293 | MCF-7 Breast | 268 / 10134 (2.6%) | 6994 / 101340 (6.9%) | −75.3 | −73.3 | 0.38 |
| FOXA1 SRX1885181 | LNCAP Prostate | 227 / 10134 (2.2%) | 6350 / 101340 (6.3%) | −75.0 | −73.1 | 0.36 |
| EP300 SRX1012643 | MCF-7 Breast | 87 / 10134 (0.9%) | 3959 / 101340 (3.9%) | −75.0 | −73.0 | 0.22 |
| FOXA1 SRX1885188 | LNCAP Prostate | 193 / 10134 (1.9%) | 5798 / 101340 (5.7%) | −74.7 | −72.7 | 0.33 |
| FOXA1 SRX2642368 | VCaP Prostate | 307 / 10134 (3.0%) | 7559 / 101340 (7.5%) | −74.7 | −72.7 | 0.41 |
| KAT7 DRX234808 | 293 Kidney | 439 / 10134 (4.3%) | 1461 / 101340 (1.4%) | −74.6 | −72.6 | 3.00 |
| FOXA1 SRX1161207 | T-47D Breast | 106 / 10134 (1.0%) | 4307 / 101340 (4.3%) | −74.6 | −72.6 | 0.25 |
| ESR1 SRX4367192 | MCF-7 Breast | 505 / 10134 (5.0%) | 10349 / 101340 (10.2%) | −74.5 | −72.5 | 0.49 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 145 / 10134 (1.4%) | 4985 / 101340 (4.9%) | −74.3 | −72.4 | 0.29 |
| SFPQ SRX593748 | MCF-7 Breast | 1613 / 10134 (15.9%) | 9880 / 101340 (9.7%) | −74.3 | −72.3 | 1.63 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 168 / 10134 (1.7%) | 5369 / 101340 (5.3%) | −74.2 | −72.2 | 0.31 |
| ARID1A SRX5089382 | MCF-7 Breast | 179 / 10134 (1.8%) | 5547 / 101340 (5.5%) | −74.1 | −72.1 | 0.32 |
| ESR1 SRX1469949 | MCF-7 Breast | 143 / 10134 (1.4%) | 4939 / 101340 (4.9%) | −74.0 | −72.0 | 0.29 |
| RBFOX2 SRX3322781 | K-562 Blood | 1143 / 10134 (11.3%) | 6240 / 101340 (6.2%) | −73.9 | −71.9 | 1.83 |
| ESR1 SRX8537723 | MCF-7 Breast | 203 / 10134 (2.0%) | 5928 / 101340 (5.8%) | −73.8 | −71.8 | 0.34 |
| ARID1A SRX5089391 | MCF-7 Breast | 145 / 10134 (1.4%) | 4967 / 101340 (4.9%) | −73.8 | −71.8 | 0.29 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 328 / 10134 (3.2%) | 7827 / 101340 (7.7%) | −73.7 | −71.7 | 0.42 |
| FOXA1 SRX1161205 | T-47D Breast | 139 / 10134 (1.4%) | 4859 / 101340 (4.8%) | −73.6 | −71.6 | 0.29 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 950 / 10134 (9.4%) | 4833 / 101340 (4.8%) | −73.4 | −71.5 | 1.97 |
| G3BP1 SRX24196609 | KGN Gonad | 921 / 10134 (9.1%) | 4626 / 101340 (4.6%) | −73.3 | −71.4 | 1.99 |
| ESR1 SRX1012629 | MCF-7 Breast | 160 / 10134 (1.6%) | 5205 / 101340 (5.1%) | −73.3 | −71.3 | 0.31 |
| CDK9 SRX20230573 | Ishikawa Uterus | 1231 / 10134 (12.1%) | 6924 / 101340 (6.8%) | −73.2 | −71.2 | 1.78 |
| ZFX SRX7805370 | 293 Kidney | 658 / 10134 (6.5%) | 2829 / 101340 (2.8%) | −73.2 | −71.2 | 2.33 |
| MYOCD SRX5598318 | A549 Lung | 954 / 10134 (9.4%) | 4870 / 101340 (4.8%) | −73.1 | −71.2 | 1.96 |
| ESR1 SRX4451214 | MCF-7 Breast | 226 / 10134 (2.2%) | 6265 / 101340 (6.2%) | −73.1 | −71.1 | 0.36 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 264 / 10134 (2.6%) | 6846 / 101340 (6.8%) | −72.9 | −71.0 | 0.39 |
| JADE3 DRX300415 | 293 Kidney | 855 / 10134 (8.4%) | 4179 / 101340 (4.1%) | −72.6 | −70.7 | 2.05 |
| FOXA1 SRX15431000 | T-47D Breast | 213 / 10134 (2.1%) | 6041 / 101340 (6.0%) | −72.6 | −70.6 | 0.35 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 225 / 10134 (2.2%) | 6230 / 101340 (6.1%) | −72.6 | −70.6 | 0.36 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 341 / 10134 (3.4%) | 7968 / 101340 (7.9%) | −72.5 | −70.6 | 0.43 |
| ESR1 SRX5323873 | MCF-7 Breast | 314 / 10134 (3.1%) | 7577 / 101340 (7.5%) | −72.5 | −70.5 | 0.41 |
| ARID1A SRX5089388 | MCF-7 Breast | 132 / 10134 (1.3%) | 4700 / 101340 (4.6%) | −72.4 | −70.5 | 0.28 |
| FOXA1 SRX142908 | LNCAP Prostate | 133 / 10134 (1.3%) | 4717 / 101340 (4.7%) | −72.4 | −70.5 | 0.28 |
| CEBPA SRX2630241 | Hep G2 Liver | 321 / 10134 (3.2%) | 7669 / 101340 (7.6%) | −72.3 | −70.3 | 0.42 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 111 / 10134 (1.1%) | 58 / 101340 (0.1%) | −72.2 | −70.2 | 19.14 |
| ESR1 SRX20282973 | MCF-7 Breast | 315 / 10134 (3.1%) | 7576 / 101340 (7.5%) | −72.1 | −70.2 | 0.42 |
| FOXA1 SRX1033292 | LNCAP Prostate | 133 / 10134 (1.3%) | 4709 / 101340 (4.6%) | −72.1 | −70.2 | 0.28 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 901 / 10134 (8.9%) | 4517 / 101340 (4.5%) | −72.0 | −70.1 | 1.99 |
| ESR1 SRX2881002 | MCF-7 Breast | 246 / 10134 (2.4%) | 6534 / 101340 (6.4%) | −72.0 | −70.1 | 0.38 |
| ESR1 SRX20282940 | MCF-7 Breast | 287 / 10134 (2.8%) | 7153 / 101340 (7.1%) | −72.0 | −70.0 | 0.40 |
| NANOG SRX10445309 | Neural crest cells Neural | 145 / 10134 (1.4%) | 4909 / 101340 (4.8%) | −71.9 | −70.0 | 0.30 |
| FOXA1 SRX1885186 | LNCAP Prostate | 171 / 10134 (1.7%) | 5345 / 101340 (5.3%) | −71.9 | −70.0 | 0.32 |
| MAU2 SRX11120892 | MCF-7 Breast | 110 / 10134 (1.1%) | 4292 / 101340 (4.2%) | −71.9 | −69.9 | 0.26 |
| BRD2 SRX8090642 | Synoviocytes Others | 626 / 10134 (6.2%) | 2649 / 101340 (2.6%) | −71.7 | −69.8 | 2.36 |
| Epitope tags SRX15725650 | 293 Kidney | 927 / 10134 (9.1%) | 4713 / 101340 (4.7%) | −71.7 | −69.8 | 1.97 |
| TEAD1 SRX3401272 | MCF-7 Breast | 206 / 10134 (2.0%) | 5898 / 101340 (5.8%) | −71.7 | −69.7 | 0.35 |
| RBM22 SRX4708083 | K-562 Blood | 528 / 10134 (5.2%) | 2036 / 101340 (2.0%) | −71.4 | −69.5 | 2.59 |
| FOXA1 SRX9604646 | LNCAP Prostate | 348 / 10134 (3.4%) | 8026 / 101340 (7.9%) | −71.4 | −69.4 | 0.43 |
| ESR1 SRX1531796 | MCF-7 Breast | 138 / 10134 (1.4%) | 4767 / 101340 (4.7%) | −71.4 | −69.4 | 0.29 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 874 / 10134 (8.6%) | 4347 / 101340 (4.3%) | −71.2 | −69.3 | 2.01 |
| FOXA1 SRX2642365 | VCaP Prostate | 242 / 10134 (2.4%) | 6443 / 101340 (6.4%) | −71.2 | −69.3 | 0.38 |
| ING2 SRX286201 | RKO Digestive tract | 796 / 10134 (7.9%) | 3802 / 101340 (3.8%) | −71.1 | −69.2 | 2.09 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 307 / 10134 (3.0%) | 7419 / 101340 (7.3%) | −71.1 | −69.2 | 0.41 |
| FOXA1 SRX3923508 | MCF-7 Breast | 81 / 10134 (0.8%) | 3728 / 101340 (3.7%) | −71.0 | −69.1 | 0.22 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 307 / 10134 (3.0%) | 7414 / 101340 (7.3%) | −71.0 | −69.1 | 0.41 |
| CTCF SRX12008350 | MCF 10A Breast | 1673 / 10134 (16.5%) | 10498 / 101340 (10.4%) | −70.7 | −68.8 | 1.59 |
| ESR1 SRX10365534 | MCF-7 Breast | 78 / 10134 (0.8%) | 3657 / 101340 (3.6%) | −70.7 | −68.8 | 0.21 |
| FOXA1 SRX5323844 | MCF-7 Breast | 71 / 10134 (0.7%) | 3522 / 101340 (3.5%) | −70.7 | −68.8 | 0.20 |
| FOXA1 SRX3923513 | MCF-7 Breast | 80 / 10134 (0.8%) | 3697 / 101340 (3.6%) | −70.7 | −68.7 | 0.22 |
| Epitope tags SRX10715360 | HCB1 Blood | 632 / 10134 (6.2%) | 2708 / 101340 (2.7%) | −70.6 | −68.7 | 2.33 |
| FOXA1 SRX3931073 | MCF-7 Breast | 155 / 10134 (1.5%) | 5024 / 101340 (5.0%) | −70.4 | −68.5 | 0.31 |
| EP300 SRX176883 | MCF-7 Breast | 121 / 10134 (1.2%) | 4443 / 101340 (4.4%) | −70.4 | −68.5 | 0.27 |
| NR3C1 SRX19024870 | MCF-7 Breast | 88 / 10134 (0.9%) | 3839 / 101340 (3.8%) | −70.4 | −68.5 | 0.23 |
| FOXA1 SRX1885187 | LNCAP Prostate | 163 / 10134 (1.6%) | 5158 / 101340 (5.1%) | −70.3 | −68.4 | 0.32 |
| INTS3 SRX3640569 | HeLa Uterus | 714 / 10134 (7.0%) | 3258 / 101340 (3.2%) | −70.3 | −68.4 | 2.19 |
| ESR1 SRX1012630 | MCF-7 Breast | 99 / 10134 (1.0%) | 4040 / 101340 (4.0%) | −70.3 | −68.4 | 0.25 |
| KMT2A SRX1293531 | MV-4-11 Blood | 1416 / 10134 (14.0%) | 8461 / 101340 (8.3%) | −70.1 | −68.2 | 1.67 |
| ESR1 SRX5323878 | MCF-7 Breast | 258 / 10134 (2.5%) | 6644 / 101340 (6.6%) | −70.1 | −68.2 | 0.39 |
| ARID1A SRX5089385 | MCF-7 Breast | 200 / 10134 (2.0%) | 5746 / 101340 (5.7%) | −70.0 | −68.1 | 0.35 |
| ESR1 SRX5323872 | MCF-7 Breast | 260 / 10134 (2.6%) | 6666 / 101340 (6.6%) | −69.8 | −67.9 | 0.39 |
| ESR1 SRX2513521 | MCF-7 Breast | 125 / 10134 (1.2%) | 4489 / 101340 (4.4%) | −69.6 | −67.7 | 0.28 |
| FOXA1 SRX752908 | LNCAP Prostate | 172 / 10134 (1.7%) | 5282 / 101340 (5.2%) | −69.6 | −67.7 | 0.33 |
| ESR1 SRX5323871 | MCF-7 Breast | 285 / 10134 (2.8%) | 7032 / 101340 (6.9%) | −69.6 | −67.7 | 0.41 |
| Epitope tags SRX15725652 | 293 Kidney | 1028 / 10134 (10.1%) | 5507 / 101340 (5.4%) | −69.6 | −67.7 | 1.87 |
| FOXA1 SRX15391842 | T-47D Breast | 150 / 10134 (1.5%) | 4913 / 101340 (4.8%) | −69.6 | −67.7 | 0.31 |
| ESR1 SRX20282953 | MCF-7 Breast | 217 / 10134 (2.1%) | 5997 / 101340 (5.9%) | −69.5 | −67.6 | 0.36 |
| RBFOX2 SRX3322782 | K-562 Blood | 1064 / 10134 (10.5%) | 5774 / 101340 (5.7%) | −69.5 | −67.6 | 1.84 |
| NR3C1 SRX1161167 | MCF-7 Breast | 67 / 10134 (0.7%) | 3405 / 101340 (3.4%) | −69.5 | −67.6 | 0.20 |
| FOXA1 SRX6878604 | LNCAP Prostate | 214 / 10134 (2.1%) | 5947 / 101340 (5.9%) | −69.4 | −67.5 | 0.36 |
| AR SRX15946405 | MDA-MB-453 Breast | 171 / 10134 (1.7%) | 5256 / 101340 (5.2%) | −69.4 | −67.5 | 0.33 |
| FOXA1 SRX1885182 | LNCAP Prostate | 223 / 10134 (2.2%) | 6081 / 101340 (6.0%) | −69.3 | −67.4 | 0.37 |
| TRPS1 SRX3401273 | MCF-7 Breast | 90 / 10134 (0.9%) | 3839 / 101340 (3.8%) | −69.2 | −67.3 | 0.23 |
| BCOR SRX10184493 | K-562 Blood | 1211 / 10134 (11.9%) | 6904 / 101340 (6.8%) | −69.0 | −67.1 | 1.75 |
| FOXA1 SRX8537736 | MCF-7 Breast | 94 / 10134 (0.9%) | 3906 / 101340 (3.9%) | −68.9 | −67.0 | 0.24 |
| NR3C1 SRX19024880 | MCF-7 Breast | 69 / 10134 (0.7%) | 3424 / 101340 (3.4%) | −68.8 | −66.9 | 0.20 |
| NCOA1 SRX036638 | U2OS Bone | 100 / 10134 (1.0%) | 44 / 101340 (0.0%) | −68.8 | −66.9 | 22.73 |
| FOXA1 SRX3931031 | MCF-7 Breast | 132 / 10134 (1.3%) | 4583 / 101340 (4.5%) | −68.8 | −66.9 | 0.29 |
| FOXA1 SRX497613 | VCaP Prostate | 193 / 10134 (1.9%) | 5585 / 101340 (5.5%) | −68.7 | −66.8 | 0.35 |
| GFP SRX12567762 | MRC-5 Lung | 1009 / 10134 (10.0%) | 5393 / 101340 (5.3%) | −68.6 | −66.7 | 1.87 |
| FOXA1 SRX2642369 | VCaP Prostate | 240 / 10134 (2.4%) | 6317 / 101340 (6.2%) | −68.6 | −66.7 | 0.38 |
| TET2 SRX2513053 | Jurkat Blood | 1174 / 10134 (11.6%) | 6635 / 101340 (6.5%) | −68.6 | −66.7 | 1.77 |
| MAU2 SRX11120893 | MCF-7 Breast | 110 / 10134 (1.1%) | 4188 / 101340 (4.1%) | −68.5 | −66.7 | 0.26 |
| AR SRX11149848 | MDA-MB-453 Breast | 173 / 10134 (1.7%) | 5254 / 101340 (5.2%) | −68.4 | −66.5 | 0.33 |
| FOXA1 SRX1961163 | T-47D Breast | 178 / 10134 (1.8%) | 5334 / 101340 (5.3%) | −68.3 | −66.4 | 0.33 |
| ESR1 SRX2578880 | MDA-MB-231 Breast | 778 / 10134 (7.7%) | 3742 / 101340 (3.7%) | −68.3 | −66.4 | 2.08 |
| GATA3 SRX11150129 | Breast cancer cells Breast | 365 / 10134 (3.6%) | 8142 / 101340 (8.0%) | −68.3 | −66.4 | 0.45 |
| FOXA1 SRX8537737 | MCF-7 Breast | 102 / 10134 (1.0%) | 4033 / 101340 (4.0%) | −68.1 | −66.3 | 0.25 |
| GATA3 SRX11150127 | ZR-75-1 Breast | 150 / 10134 (1.5%) | 4860 / 101340 (4.8%) | −68.0 | −66.2 | 0.31 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 240 / 10134 (2.4%) | 6295 / 101340 (6.2%) | −68.0 | −66.1 | 0.38 |
| ESR1 SRX20282971 | MCF-7 Breast | 268 / 10134 (2.6%) | 6716 / 101340 (6.6%) | −67.9 | −66.1 | 0.40 |
| FOXA1 SRX6860646 | T-47D Breast | 156 / 10134 (1.5%) | 4956 / 101340 (4.9%) | −67.9 | −66.0 | 0.31 |
| FOXA1 SRX3923510 | MCF-7 Breast | 104 / 10134 (1.0%) | 4059 / 101340 (4.0%) | −67.9 | −66.0 | 0.26 |
| FOXA1 SRX9604649 | LNCAP Prostate | 323 / 10134 (3.2%) | 7520 / 101340 (7.4%) | −67.8 | −66.0 | 0.43 |
| PHF6 SRX11508322 | G-401 Kidney | 496 / 10134 (4.9%) | 1900 / 101340 (1.9%) | −67.8 | −66.0 | 2.61 |
| ESR1 SRX2513517 | MCF-7 Breast | 181 / 10134 (1.8%) | 5360 / 101340 (5.3%) | −67.7 | −65.9 | 0.34 |
| FOXA1 SRX497611 | VCaP Prostate | 208 / 10134 (2.1%) | 5790 / 101340 (5.7%) | −67.7 | −65.9 | 0.36 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 269 / 10134 (2.7%) | 6722 / 101340 (6.6%) | −67.7 | −65.8 | 0.40 |
| FOXA1 SRX5323830 | T-47D Breast | 167 / 10134 (1.6%) | 5132 / 101340 (5.1%) | −67.7 | −65.8 | 0.33 |
| FOXA2 SRX3322259 | Hep G2 Liver | 174 / 10134 (1.7%) | 5240 / 101340 (5.2%) | −67.6 | −65.7 | 0.33 |
| FOXA1 SRX2017928 | LNCAP Prostate | 309 / 10134 (3.0%) | 7305 / 101340 (7.2%) | −67.5 | −65.6 | 0.42 |
| ESR1 SRX5323877 | MCF-7 Breast | 211 / 10134 (2.1%) | 5825 / 101340 (5.7%) | −67.5 | −65.6 | 0.36 |
| CSTF2 SRX10722980 | U2OS Bone | 432 / 10134 (4.3%) | 1522 / 101340 (1.5%) | −67.4 | −65.6 | 2.84 |
| MethylCap SRX026646 | Acute myeloid leukemia Blood | 357 / 10134 (3.5%) | 1103 / 101340 (1.1%) | −67.4 | −65.5 | 3.24 |
| FOXA1 SRX5323850 | MCF-7 Breast | 68 / 10134 (0.7%) | 3362 / 101340 (3.3%) | −67.4 | −65.5 | 0.20 |
| FOXA1 SRX3931083 | MCF-7 Breast | 158 / 10134 (1.6%) | 4968 / 101340 (4.9%) | −67.3 | −65.4 | 0.32 |
| ESR1 SRX1469951 | MCF-7 Breast | 138 / 10134 (1.4%) | 4634 / 101340 (4.6%) | −67.3 | −65.4 | 0.30 |
| KAT6A DRX366109 | 293 Kidney | 1148 / 10134 (11.3%) | 6476 / 101340 (6.4%) | −67.3 | −65.4 | 1.77 |
| FOXA1 SRX667985 | VCaP Prostate | 211 / 10134 (2.1%) | 5817 / 101340 (5.7%) | −67.2 | −65.3 | 0.36 |
| FOXA1 SRX6878606 | LNCAP Prostate | 138 / 10134 (1.4%) | 4628 / 101340 (4.6%) | −67.2 | −65.3 | 0.30 |
| ESR1 SRX2513520 | MCF-7 Breast | 168 / 10134 (1.7%) | 5126 / 101340 (5.1%) | −67.1 | −65.3 | 0.33 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 261 / 10134 (2.6%) | 6581 / 101340 (6.5%) | −67.1 | −65.2 | 0.40 |
| Crotonyllysine SRX12024488 | Polycystic kidney Kidney | 1502 / 10134 (14.8%) | 9261 / 101340 (9.1%) | −67.0 | −65.2 | 1.62 |
| KMT2A SRX8151120 | VDH-15 Others | 1153 / 10134 (11.4%) | 6525 / 101340 (6.4%) | −67.0 | −65.1 | 1.77 |
| KAT6A DRX366108 | 293 Kidney | 959 / 10134 (9.5%) | 5073 / 101340 (5.0%) | −67.0 | −65.1 | 1.89 |
| BRD4 SRX23813262 | C4-2B Prostate | 860 / 10134 (8.5%) | 4355 / 101340 (4.3%) | −67.0 | −65.1 | 1.97 |
| ESR1 SRX20282959 | MCF-7 Breast | 115 / 10134 (1.1%) | 4220 / 101340 (4.2%) | −66.8 | −65.0 | 0.27 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 845 / 10134 (8.3%) | 4254 / 101340 (4.2%) | −66.7 | −64.9 | 1.99 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 235 / 10134 (2.3%) | 6167 / 101340 (6.1%) | −66.7 | −64.8 | 0.38 |
| FOXA1 SRX6860640 | T-47D Breast | 123 / 10134 (1.2%) | 4353 / 101340 (4.3%) | −66.6 | −64.8 | 0.28 |
| KMT2A SRX8151116 | VDH-15 Others | 938 / 10134 (9.3%) | 4929 / 101340 (4.9%) | −66.6 | −64.8 | 1.90 |
| KDM6A SRX15826236 | MCF-7 Breast | 88 / 10134 (0.9%) | 3722 / 101340 (3.7%) | −66.5 | −64.7 | 0.24 |
| GATA3 SRX11149845 | MDA-MB-453 Breast | 279 / 10134 (2.8%) | 6827 / 101340 (6.7%) | −66.5 | −64.7 | 0.41 |
| MEN1 SRX11712604 | K-562 Blood | 772 / 10134 (7.6%) | 3745 / 101340 (3.7%) | −66.4 | −64.6 | 2.06 |
| ESR1 SRX3110720 | MCF-7 Breast | 113 / 10134 (1.1%) | 4171 / 101340 (4.1%) | −66.4 | −64.5 | 0.27 |
| FOXA1 SRX2642366 | VCaP Prostate | 262 / 10134 (2.6%) | 6563 / 101340 (6.5%) | −66.2 | −64.4 | 0.40 |
| CEBPA SRX4705113 | MOLM-13 Blood | 610 / 10134 (6.0%) | 11372 / 101340 (11.2%) | −66.2 | −64.4 | 0.54 |
| FOXA1 SRX497610 | VCaP Prostate | 234 / 10134 (2.3%) | 6132 / 101340 (6.1%) | −66.2 | −64.3 | 0.38 |
| ESR1 SRX176856 | MCF-7 Breast | 95 / 10134 (0.9%) | 3842 / 101340 (3.8%) | −66.1 | −64.3 | 0.25 |
| STAT1 SRX23678708 | K-562 Blood | 836 / 10134 (8.2%) | 4206 / 101340 (4.2%) | −66.1 | −64.2 | 1.99 |
| FOXA1 SRX1212232 | LNCAP Prostate | 217 / 10134 (2.1%) | 5869 / 101340 (5.8%) | −66.1 | −64.2 | 0.37 |
| ESR1 SRX2901942 | Ishikawa Uterus | 641 / 10134 (6.3%) | 2860 / 101340 (2.8%) | −66.0 | −64.2 | 2.24 |
| FOXA1 SRX1033276 | LNCAP Prostate | 188 / 10134 (1.9%) | 5407 / 101340 (5.3%) | −65.8 | −64.0 | 0.35 |
| ESR1 SRX3110723 | MCF-7 Breast | 153 / 10134 (1.5%) | 4833 / 101340 (4.8%) | −65.8 | −63.9 | 0.32 |
| FOXA1 SRX10468635 | Breast cancer cells Breast | 231 / 10134 (2.3%) | 6072 / 101340 (6.0%) | −65.7 | −63.9 | 0.38 |
| FOXA1 SRX9604648 | LNCAP Prostate | 334 / 10134 (3.3%) | 7595 / 101340 (7.5%) | −65.7 | −63.9 | 0.44 |
| NR3C1 SRX1161182 | ZR-75-1 Breast | 69 / 10134 (0.7%) | 3335 / 101340 (3.3%) | −65.7 | −63.9 | 0.21 |
| RBFOX2 SRX3323051 | Hep G2 Liver | 829 / 10134 (8.2%) | 4166 / 101340 (4.1%) | −65.7 | −63.9 | 1.99 |
| ESR1 SRX1012633 | MCF-7 Breast | 145 / 10134 (1.4%) | 4697 / 101340 (4.6%) | −65.5 | −63.7 | 0.31 |
| MYCN SRX9821833 | SH-EP Neural | 740 / 10134 (7.3%) | 3547 / 101340 (3.5%) | −65.5 | −63.6 | 2.09 |
| FOXA1 SRX3923525 | ZR-75-1 Breast | 98 / 10134 (1.0%) | 3870 / 101340 (3.8%) | −65.4 | −63.5 | 0.25 |
| FOXA2 SRX11650941 | hESC derived pancreatic cells Pluripotent stem cell | 140 / 10134 (1.4%) | 4601 / 101340 (4.5%) | −65.3 | −63.5 | 0.30 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 145 / 10134 (1.4%) | 4686 / 101340 (4.6%) | −65.3 | −63.5 | 0.31 |
| AR SRX9109110 | MDA-MB-453 Breast | 499 / 10134 (4.9%) | 9856 / 101340 (9.7%) | −65.2 | −63.4 | 0.51 |
| FOXA1 SRX2642367 | VCaP Prostate | 238 / 10134 (2.3%) | 6160 / 101340 (6.1%) | −65.2 | −63.3 | 0.39 |
| FOXA1 SRX10024492 | MCF-7 Breast | 60 / 10134 (0.6%) | 3138 / 101340 (3.1%) | −65.1 | −63.3 | 0.19 |
Showing first 500 of 13995 rows.